Fong Clow

Fong Clow, D.Sc., is our Head of Biometrics and Clinical Operations. She provides strategic leadership and analysis to the product development cycle.

Dr. Clow brings over 30 years of experience, leading extensive teams in biometrics and drug development. She joined us from Pharmacyclics, an AbbVie company, where she was the SVP of Biostatistics, Statistical Programming, and Clinical Data Management. Dr. Clow started her career at Syntax, a big pharmaceutical company. She worked in Genentech for more than 8 years, where she was a clinical team leader for a big international collaboration project. She has worked in both public and private biotech companies. At Novacea Dr. Clow was SVP of Drug Development, leading the full scope of the company’s drug development. She also worked as a consultant for many companies, as well as a Managing Director of a private investment company.

Dr. Clow has had 14 successful NDA / BLA submissions and approvals in cardiovascular, neurology and oncology. She led the team that submitted the first full electronic BLA submission in 1995. She has received multiple awards for her accomplishments and contributions, including the 2019 Lagakos Distinguished Alumni Award from Harvard T.H. Chan School of Public Health.

Dr. Clow has published over 60 manuscripts and conference abstracts, and a patent. Dr. Clow received her Doctor of Science and Master of Science degrees from Harvard School of Public Health. Dr. Clow is fluent in Chinese.